Crossmark

Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials

Crossref DOI link: https://doi.org/10.1007/s00705-022-05407-9

Published Online: 2022-03-15

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shoja, Zabihollah https://orcid.org/0000-0001-5617-5844
Jalilvand, Somayeh

Latifi, Tayebeh

Roohvand, Farzin
Funding

Funding for this research was provided by:

Pasteur Institute of Iran (1097)
License Information

Text and Data Mining valid from 2022-03-15

Version of Record valid from 2022-03-15
More Information

Article History

Received: 18 December 2021

Accepted: 26 January 2022

First Online: 15 March 2022

Declarations

:

: The authors declare no conflicting financial or other interests.

Document is current

Any future updates will be listed below